chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid and arthritis. The patient was allergic to pain medications (reported as pain meds). Concomitant medications were reported as levothyroxine (MANUFACTURER UNKNOWN), meloxicam (MANUFACTURER UNKNOWN), vitamin D (MANUFACTURER UNKNOWN) and lysine (MANUFACTURER UNKNOWN), all for unknown indication and from an unknown date. It was unknown, if the patient was diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, one week after injection the patient experienced sore and swollen lymph glands for 48 hours. The adverse events did not result in doctor or other healthcare professional office/clinic visit. The clinical outcome of swollen lymph nodes and lymph node pain was resolving at the time of this report.   No follow-up attempts are needed. Information about lot/ batch number cannot be obtained.
Soreness in shoulder that increased over several weeks. Patient still experienced sharp pain. Patient was diagnosed w/ tendinitis.
first 48-52 hours were like torture; call it brain fog, have no cognitive ability; couldn't go out of bed; couldn't get comfortable; couldn't eat; it was hard to sleep; was tremendously weak; winded, it was hard to catch breath; feel achy literally all over; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (first 48-52 hours were like torture), FEELING ABNORMAL (call it brain fog, have no cognitive ability), BEDRIDDEN (couldn't go out of bed), DISCOMFORT (couldn't get comfortable) and FEEDING DISORDER (couldn't eat) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included COVID-19 (kept him sick until he got the second dose of the vaccine) since September 2020 and COVID-19 (beginning of April 2021, COVID-sick for 8 months up until he received the second dose of the vaccine.) since April 2021.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced VACCINATION COMPLICATION (first 48-52 hours were like torture), FEELING ABNORMAL (call it brain fog, have no cognitive ability), BEDRIDDEN (couldn't go out of bed), DISCOMFORT (couldn't get comfortable), FEEDING DISORDER (couldn't eat), INSOMNIA (it was hard to sleep), ASTHENIA (was tremendously weak), DYSPNOEA (winded, it was hard to catch breath), MYALGIA (feel achy literally all over) and FATIGUE (Fatigue). In April 2021, VACCINATION COMPLICATION (first 48-52 hours were like torture), FEELING ABNORMAL (call it brain fog, have no cognitive ability), BEDRIDDEN (couldn't go out of bed), DISCOMFORT (couldn't get comfortable), FEEDING DISORDER (couldn't eat), INSOMNIA (it was hard to sleep), ASTHENIA (was tremendously weak), DYSPNOEA (winded, it was hard to catch breath), MYALGIA (feel achy literally all over) and FATIGUE (Fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient received his vaccine on his left side. Patient takes concomitant medication for many years  but it was not reported.  COVID test was not done. No treatment information was reported.    This case was linked to MOD-2021-435744, MOD-2021-435745 (Patient Link).
Pt had the following reaction: Stood up to leave, began to feel dizzy, reported itching to right finger and back of head on left side. Pt returned to chair, given water and fruit snack. No return of dizziness, VS updated, pt monitored for 15 minutes then requested to go home, no rash noted, aware to return if worse and report symptoms if return.
Initial report was received from a health care professional on 23 October 2012. An 11-year-old female patient had received an injection of MENACTRA, lot number U4267AB (route, site and date of administration not reported) and an unspecified amount of time later experienced a rash at the site of injection that formed a blister and small bumps with pus in them. The physician did a culture of the bumps but has not received results yet. The injection site was also swollen and red. No further information was provided. The patient's outcome was not reported. Documents held by sender: None.
Sore right arm briefly; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Sore right arm briefly) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hyperlipidaemia and GERD. Concomitant products included PANTOPRAZOLE for GERD, ATORVASTATIN for Hyperlipidemia, GABAPENTIN, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), LAMOTRIGINE, CITALOPRAM and LUBIPROSTONE for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore right arm briefly). At the time of the report, VACCINATION SITE PAIN (Sore right arm briefly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
No adverse event; Patient received expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 10-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     Relevant medical history/conditions, allergy, concomitant diseases and risk factor was unknown.   On 28-Feb-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine).    No concomitant medications were reported.  No adverse events were reported.  No treatment medications were reported.  This case contains information for the 1st of 6th adult patients described by the reporter.
WITHIN 5 MINUTES, PT BECAME VERY HOT AND DIAPHORETIC AND MILDLY NAUSEAUS
Face rash; Low grade fever; Body aches; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history included allergy to Pecan. Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced face rash, low grade fever, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events face rash, low grade fever, body aches and chills were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Last PM temp up to 103 - today 102.6 - left arm hurts and slightly swollen - left hand pain "tingles" - fatique - today slight cough - eyes watery - no appetite
Mom called to report reactions to vaccine which includes left leg pain, left lower thigh and knee swelling, tenderness, limping, difficulty bending and straightening knee.
I received SHINGRIX 1st shot and about 3 hours later began to feel ill. Experienced chills, nausea, low grade fever, very tired with no energy, whole body ached, headache, pain and discomfort in shoulders and joints, developed rash on buttocks, no appetite, exhausted, trouble sleeping. These severe symptoms lasted about 3 days with gradual improvement, for me it took an entire week to feel back to normal. I am hopeful that when I receivedthe second shot in 4 months that my side effects will be less severe. The symptoms I experienced made me feel the sickest and unwell I have felt in years. Even when I have experienced flu like symptoms I did not feel as ill as I did after receiving this injection. The injection was also very painful, not the needle stick but the length of time to inject the product. It felt like someone was trying to inject a thick substance into my arm and very painful during that process. Arm at injection site lump and very sore for a few days. Worst experience I ever had with getting a injection. I am 70 years old male and relatively healthy, not obese and very mobile. I was very unprepared for the side effects I experienced and believe caregivers should better prepare patients on what to expect regarding the severity of possible symptoms and the length of time until the adverse reactions subside. I only report my experience to forewarn, for I will gladly tolerate the side effects if it protects one from getting shingles. This shot should not be given to sissys for they will think they are dying and rush to the ER or be calling the undertaker.
The patient received his 2nd dose of the Pfizer Covid Vaccine at Pharmacy on 9/4/2021. The patient reports he had a fever of 102 F that afternoon approximately 4 hours after the vaccine. On day two post vaccine he noticed some swelling in the right side of his face. He called a telehealth doctor and was instructed to take Benadryl. He did this and his symptoms improved. He states he had a itchy rash on his back and arms that appeared on 9/5/2021, he had his wife apply lavendar oil for several days in a row the rash has dissipated.  On 9/8/2021 the patient states he had right sided facial swelling again with swelling in his feet bilaterally. He did not take any medication for these symptoms and came to Redicare on 9/9/2021. He was treated with 8mg of dexamethasone and was instructed to start 10 mg of prednisone daily on 9/10/2021 x 10 days. Follow up with his PCP, go to ER if any breathing difficulty, change in mentation
the patient received an improperly stored dose of RECOMBIVAX; This spontaneous report was received from a nurse, regarding a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not reported.  On 15-NOV-2019, the patient was vaccinated with an improperly stored dose of hepatitis b vaccine (recombinant) (thimerosal free) (RECOMBIVAX HB) 5 microgram (mcg) per 0.5 milliliter (ml) (dose, route of administration and anatomical site of vaccination  were not reported; lot number R021372 has been verified to be a valid lot number, expiration date 25-MAY-2021) as prophylaxis (product storage error). The vaccine was stored at a temperature of 25 degrees Farenheit (°F) for 6 hours and 28 minutes, and at a temperature of 55 °F for 7 hours. There was no previous temperature excursion. The digital data logger was involved.
pt devel rash & fever 100-102 4 days p/vax were given; visit to ER on 16AUG92 w/dx of allergic rxn to ?; 17AUG92 pt's rash turned black w/swelling of face, feet, & hands adm to hosp for 4 days;
Pfizer-BoiTech COVID-19 Vaccine   Immediate burning at injection site following dose. (Similar to the sensation of receiving contrast for a CT scan) which I found odd. Injection site pain continued over night, swelling and site redness to follow and A 1.5 inch welt appeared  approx 24hrs after receiving vaccine. Pain is localized to the injection site only . Treatment includes rest and Tylenol with little effect. Continuing to monitor for any further developments or additional side effects.
Left deltoid red, swollen and hot. Time course, two days after injection. Treatment, Motrin prn.
Case number PHEH2014US011889 is an initial report received from a nurse on 11 Jun 2014. This report refers to an adult female patient in her thirties. Her past medical history included fear of needles and her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: not reported) intramuscularly at a dose of 0.5 ml on 29 Jan 2014. On the same day after the vaccination, she got dizzy and passed out for 20-30 seconds. She also urinated and vomited. The reporter stated that the patient had previously experienced the same. The outcome of the events was not reported. The events were assessed as non serious by the reporter but were reassessed as serious upon internal review. The reporter stated that the fear of needles made the patient faint. The causality of other events was not reported.
As soon as the patient received the shot she started bleeding  and a bump formed. She had a bruise form within a few minutes
pt recv vax 30SEP97 & 4OCT97 pt devel a case of chickenpox that was full blown by 6OCT97;
Swelling began about 1600hrs, followed shortly by itching. (L) deltoid. C/O itching/soreness during night. Pain/soreness 4/10, itching 4/10. Limited ROM, abducts Kw/ difficulty. Erythema 45 x 105 cm. No at-home remedies attempted.
Rash started right upper arm on 11/09, come and goes with itches, using HC.  11/17/2003-seen and treated with Keflex 20/uL for 10 days and Elocon cream twice daily as needed.
Immediately felt dizzy & vertigo-ish, w/in 30mins I had to lay down, violent migraine,  pain behind eyes , radiated through neck, upper back, shoulder. Felt better the next day, then one week later migraine persisted & all covid symptoms returned at an alarming rate.  Fatigue, fever, hot/cold sweats. Freezing & burning up at the same time. Migraine w/vertigo, loss of taste, no appetite,  restlessness, brain fogged , short term memory loss, blurred vision,  ringing in ears. Vertigo/migraine also worsened w/change in weather, before rain, or a drop in barometric pressure, or increase in humidity, or a cold front coming in.  Any drastic temperature change outside seems to prompt or increase the migraine/vertigo,  dizziness.
She felt little redness in the area like a little rash, it occurred like after 3-4 days after the shot and still little pink; She felt little redness in the area like a little rash, it occurred like after 3-4 days after the shot and still little pink; This is a spontaneous report from a contactable consumer or other non hcp (patient daughter). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced she felt little redness in the area like a little rash, it occurred like after 3-4 days after the shot and still little pink. Reporter stated, I am actually for my mother she got her Pfizer vaccine, her first one almost 3 weeks ago, Wednesday, it will be three weeks on Wednesday. And she felt little redness in the area like a little rash, it occurred like after 3-4 days after the shot and still little pink. But she didn't feel anything from it what just occurred after the shot so, she wants to get the second one, but she thought maybe she should wait a little bit wait till next week. The outcome of events was unknown.   Information on lot/batch number has been requested.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
The patient received a booster dose of Moderna following an initial dose on J&J in April 2021.  Approximately 8 minutes after vaccination patient went to stand up from his chair in the waiting area and passed out. Patient bumped his head and was very disoriented and confused as to what happened.  blood pressure was taken and was 117/62 heartrate was 66.  Patient was given time to recover, and a bottle of water and approximately 20 minutes later his blood pressure was 122/80 and heart rate was 77.  Patient denied a need for further medical care and stated would follow up with ER if dizziness persisted.
Left shoulder & arm reddened, swollen and very painful. After 2 days, severe itching started. One week later, the arm is still sensitive and flushed pink in appearance. I am not looking for compensation but wanted to share this information with the manufacturers.
Patient received PPV23 01/26/2011 at approx 1:30 PM.  States not too long after she got home area swelled up and became painful and red.  Relates redness and swelling lasted 4 days, and after 6 days still has some soreness but other symptoms are gone.  Pt had taken Benadryl and Tylenol when she had symptoms.  Did not seek medical attention, just called a clinic employee at home.
Sunday chills/fever. Monday/Tuesday redness, soreness, itch on left arm. Pt. will see MD on 11-4-15.
Day1 - of vaccine- tired (thurs). Day 2- diarrhea and fatigue, minor chills, low appetite, able to work (fri).  Day 3- Sat early day- fatigue, no appetite. Sat evening 6pm- felt good, had  energy to go for walk.  (day 3)  Day 4- early Sunday 3:am severe chills. Body shaking, couldn't get warm. Laid on heating pad for hours, Moderate body pain, moderate aches. Overall, lasted from 3am- 9am.  Severe chills- 3 hrs 3am-6am.  Took Tylenol at 4:30 (when I could finally get up) this helped a little.  Drank electrolyte drink.  Cancelled work. Took temperature at 7- no fever.  Current status:  fatigue, muscle aches, mild chills, mild dizziness, spacey thoughts. No severe chills at this time.
Pfizer-BioNTech COVID-19 Vaccine EUA.   Day one was fine.  actually no events not even arm pain. Pretty much 24 hours later I felt like I had an upset stomach. Which turned into diarrhea and a good bit of dizziness.   I slept for 2 hr but felt fine the next day.
Back ache; Severe nausea; Low grade fever (100); Chills; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151), via an unspecified route of administration in the left arm on 13Apr2021 at 09:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfa drugs). Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 15:00, the patient experienced severe nausea, low grade fever (100), chills, soreness at injection site, and back ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent SARS-CoV-2 test (nasal swab) and the result was negative. On 13Apr2021 at 15:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100 (units unspecified). The clinical outcome of the events severe nausea, low grade fever (100), chills, soreness at injection site, and back ache were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Same day nurse notes:  After patient left room, about 10 minutes, parents returned to nurse station to show how the patient's face looked like.  Patient had few bumps, red and raised on his face.  Nurse assessment did not show any other bumps on his body or area of injections.  Patient denied itching.  No trouble breathing.  Patient was assessed by Dr. Same day provider notes:  Provider called for evaluation after vaccination on 3/29/13.  Patient was seen and evaluated soon after nurse visit for vaccinations.  Patient was feeling well but started to develop hives and red bumps on face.  Bumps raised wheals and papules.  Evaluation was performed.  Patient was in no respiratory distress.  No signs of lip swelling or edema.  Lungs were clear.  Patient was instructed to go home with careful observation.  Benadryl for the symptoms and go to hospital if he develops worsening symptoms such as respiratory distress. Third day after, nurse notes:  Talked to patient's father and stated is doing pretty good, after getting home and giving Tylenol to patient, bumps disappeared. (Disappeared same day of immunization administration.  Patient's dad said he gave Tylenol.) NIPINFO response: Hello, Thank you for your question. Unfortunately, we do not diagnose clinical scenarios. Contraindications to further vaccine doses include a severe anaphylactic reaction to a previous vaccine dose or its components. This does not appear to be the case here. Rashes at the injection site are common after inactivated vaccines within 1 or 2 days after vaccination. If there is concern of an allergic reaction, we recommend follow up with a pediatric allergist. Also consider checking for latex allergy in this patient. Whether or not a provider believes that a vaccine(s) caused a reaction, we still recommend that you make a report to VAERS. . Thanks.
Patient was given Pfizer covid 19 vaccine Age 5-11 by a LPN who is supervised by me.  The nurse is allowed to give the vaccine without my presence.  The patient was given the vaccine on 09/09/2022. The vaccine was expired on 08/31/2022.  The parent was notified of the event on 09/16/2022.
Migraine; This is a spontaneous report from a contactable Other HCP reported for self. This 48-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 20Dec2020 via intramuscular at single dose (Lot # EH9899) for Covid 19 vaccine. None medical history and concomitant medications included. She got the first Covid 19 vaccine yesterday (20Dec2020) and got migraine one hour after on 20Dec2020. Stated that it has not gone away. Was not sure if specific course of action for headache since it did not occur until after 15 minutes. Outcome of the event was not recovered. Event assessed as serious (Other medically important condition).; Sender's Comments: The reported migraine was possibly related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) due to temporal relationship.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.